Michael McDonnell - Quintiles IMS Insider

Quintiles IMS Holdings Inc -- USA Stock  

USD 101.82  1.21  1.17%

CFO, Executive Vice President

Mr. Michael R. McDonnell is a Executive Vice President, Chief Financial Officer of the Company., effective December 2015. Prior to joining us, he was the Executive Vice President and Chief Financial Officer of Intelsat, a leading global provider of satellite services, from November 2008 until December 2015. He was previously Executive Vice President, Chief Financial Officer and Treasurer of MCG Capital Corporationrationration, a publiclyheld commercial finance company, from September 2004 and its Chief Operating Officer from August 2006 through October 2008. From August 2000 to August 2004, Mr. McDonnell was employed by EchoStar Communications Corporationrationration, a directtohome satellite television operator, where he served as Executive Vice President and Chief Financial Officer from July 2004 to August 2004 and as Senior Vice President and Chief Financial Officer from August 2000 to July 2004. Prior to joining EchoStar, from 1986 to 2000 Mr. McDonnell was employed by PricewaterhouseCoopers LLP, where he was a partner from 1996. He also served on the board of directors of Catalyst Health Solutions, Inc., a pharmacy benefit management company, from 2005 to 2012
Age: 52  President Since 2015      
919-998-2000  www.quintiles.com
McDonnell has a BS degree in accounting from Georgetown University and is a certified public accountant.

Management Efficiency

The company has return on total asset of 4.12 % which means that for every 100 dollars spent on asset it generated profit of $4.12. This is acceptable considering the industry classification. Similarly, it shows return on equity (ROE) of 2.25 % implying that it made 2.25 on every $100 invested by shareholders.
The company has accumulated 8.97 B in total debt with debt to equity ratio (D/E) of 115.3 implying that the company may be unable to produce cash to meet its debt commitments. Quintiles IMS Holdings Inc has Current Ratio of 1.21 implying that it may have difficulties to pay its interest payments when they become due.

Similar Executives

Showing few of many executives

PRESIDENT Since

Georges VosAbbott Laboratories
2013
Ronald HuttonBio Rad Laboratories Inc
2012
Matthew MalettaEndo International plc
2015
Joseph ManningAbbott Laboratories
2017
JeanYves PaveeAbbott Laboratories
2015
Andrew LaneAbbott Laboratories
2015
J WhiteAbbott Laboratories
2013
Michael WarmuthAbbott Laboratories
2012
Amit SachdevVertex Pharmaceuticals Incorpor
2017
Jeffrey ChodakewitzVertex Pharmaceuticals Incorpor
2014
Stephen FussellAbbott Laboratories
2013
Murthy SimhambhatlaAbbott Laboratories
2013
Antonio PeraEndo International plc
2016
Michael CrowleyBio Rad Laboratories Inc
2014
Charles FoltzAbbott Laboratories
2013
Deepak NathAbbott Laboratories
2015
Paul NavarreAllergan plc
Robert FordAbbott Laboratories
2015
Robert FunckAbbott Laboratories
2013
John HertiaBio Rad Laboratories Inc
2014
Camille FarhatEndo International plc
2012

Entity Summary

Quintiles IMS Holdings, Inc. offer biopharmaceutical development services and commercial outsourcing services in the Americas, Europe, Africa, and the AsiaPacific. Quintiles IMS Holdings Inc (Q) is traded on New York Stock Exchange in USA. It is located in NORTH CAROLINA, U.S.A and employs 36,100 people. Quintiles IMS is listed under Business Services category by Fama And French industry classification.

Did you try this?

Run Idea Optimizer Now
   

Idea Optimizer

Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Hide  View All  Next  Launch Idea Optimizer
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Quintiles IMS Holdings Inc to your portfolio

Top Management

Quintiles IMS Holdings Leadership Team
Ari Bousbib, Director, MBA
Michael Evanisko, Director
Leonard Schaeffer, Director
James Erlinger, President, MBA
John Danhakl, Director, MBA
Michael McDonnell, President
Kevin Gordon, COO
John Leonard, Director, Ph.D
James Fasano, Director, MBA
Jonathan Coslet, Director, MBA
Anand MD, Executive
Christopher Gordon, Director, MBA
John Connaughton, Director, MBA
Haiyuan Lo, Director
Dennis Gillings, Chairman, Ph.D
Todd Sisitsky, Director, MBA
Jack Greenberg, Director, CPA
Thomas Pike, CEO
Fred Cohen, Director
Richard Staub, President
MRCA MBBS, Executive
Mireille Gillings, Director, Ph.D
Richard Relyea, Director
Ronald Rittenmeyer, Director, MBA
Kevin Knightly, President

Stock Performance

Quintiles IMS Performance Indicators